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Background: PAG/Cbp represents a ubiquitous mechanism for regulating Src family kinases by recruiting Csk to
the plasma membrane, thereby controlling cellular activation. Since Src kinases are known oncogenes, we used
RNA interference in primary human T cells to test whether the loss of PAG resulted in lymphocyte transformation.
Results: PAG-depletion enhanced Src kinase activity and augmented proximal T-cell receptor signaling; exactly the
phenotype expected for loss of this negative regulator. Surprisingly, rather than becoming hyper-proliferative,
PAG-suppressed T cells became unresponsive. This was mediated by a Fyn-dependent hyper-phosphorylation of
the inhibitory receptor CTLA-4, which recruited the protein tyrosine phosphatase Shp-1 to lipid rafts. Co-suppression of
CTLA-4 abrogates this inhibition and restores proliferation to T cells.
Conclusion: We have identified a fail-safe mechanism as well as a novel contribution of CTLA-4 to setting the
activation threshold in T cells.
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Tcells orchestrate the adaptive immune response. However,
to fulfill this function they must first be activated by specific
antigenic peptides presented by MHC molecules. How T
cells are able to distinguish self antigens from foreign is an
important question, as inappropriate activation may lead to
autoimmunity. It was long held that self-reactive T cells are
deleted in the thymus. However, the presence of mecha-
nisms that induce peripheral tolerance, as well as the ob-
servation that both peripheral conventional and regulatory
T cells can be self-reactive has challenged this view. Al-
though it is now accepted that autoreactive T cells escape
the thymus [1], it remains unclear how the threshold for
activation is set to ensure that these potentially destructive* Correspondence: jon.lindquist@med.ovgu.de
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reproduction in any medium, provided the orcells remain quiescent. The activation threshold for T cells
appears to be determined by a number of TCR-induced
proximal feedback loops [2]. One such loop involves the
tight control over the activation of Src family kinases, Lck
and Fyn [3], by the phosphoprotein associated with
glycosphingolipid-enriched microdomains (PAG), also
known as the Csk binding protein (Cbp); a transmem-
brane adaptor protein [hereafter referred to as PAG].
The primary function of PAG appears to be recruiting
the C-terminal Src kinase (Csk) to the plasma membrane,
where Csk then phosphorylates the inhibitory tyrosines lo-
cated near to the carboxy terminus of the Src kinases [4-6].
The phosphorylated C-terminus binds intramolecularly to
the SH2 domain leading to the formation of a closed-
inactive conformation [7-9]. In agreement with this mech-
anism, PAG over-expression inhibits T-cell activation [4,10].
As PAG, Csk, and the Src kinases are all ubiquitously
expressed proteins, this regulatory circuit may be im-
portant in many cellular systems. Indeed, PAG has been
demonstrated to regulate cellular transformation. Intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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shown to positively correlate with proliferation [11].
Whereas in B-cell Non-Hodgkin’s Lymphoma (B-NHL)
PAG contributes to transformation by maintaining Lyn
in an open conformation [12]. Recently, PAG was also
described as a tumor suppressor, due to its ability to
bind and thereby sequester Src kinases away from their
substrates [13]. However, the exact role of PAG in regu-
lating transformation appears to be context-dependent,
as PAG has been demonstrated to be absent or present
in a number of lymphomas [14].
In addition to inhibiting Src kinases, we have also shown
that PAG negatively regulates Ras [15]. PAG also restricts
the mobility of lipid rafts within the membrane via
its binding to the cytoskeletal adaptor EBP-50 [16,17].
Since the data suggest that PAG is an important negative
regulator, a Pag1 knockout was predicted to have a severe
phenotype, as the Csk knockout is embryonic lethal
[18,19]. However, as Pag1 knockout mice possess no ap-
parent defects, the importance of PAG as a negative regu-
lator has been questioned [20,21]. Our investigation of
these mice revealed that a constitutive Pag1 knockout de-
velops a compensatory mechanism [22], suggesting that
the use of conventional knockout mice is not the best
strategy to investigate PAG function. Therefore to address
whether the loss of PAG would result in lymphocyte
transformation, we used RNA inhibition to investigate
PAG function in primary human T cells.
As the suppression of murine PAG expression by siRNA
was previously reported in fibroblasts [23], we utilized
the corresponding RNA-sequences to target human PAG
[15,24]. We found that PAG suppression in human T cells
led to enhanced Src kinase activity, which was reflected
by increased phosphorylation of the activatory tyrosine.
Additionally, we detected both enhanced basal tyrosine
phosphorylation, as well as an enhanced TCR-induced
phosphorylation, including the activation of key proteins
such as ZAP-70 and PLCγ1. However despite showing en-
hanced proximal signaling, the proliferation of PAG-
deficient cells was dramatically reduced. Thus, it appears
that other negative regulatory feedback loops have been
activated that induced a state of unresponsiveness within
these T cells. We further show that this involves a negative
feedback loop via the inhibitory receptor CTLA-4, which
recruits the phosphatase Shp1, and, in this way, prevents
strong proximal signals from being translated into en-
hanced T-cell activation.
Results
PAG suppression enhances proximal signaling in human
T cells
To determine the function of PAG, the Jurkat T cell line
was transfected with plasmids encoding PAG shRNA
and the kinetic of PAG suppression monitored byWestern blotting (Additional file 1: Figure S1). Upon
PAG suppression, we observed an increase in the basal
kinase activity of both Fyn and Lck, as measured by
in vitro kinase assays (IVKs) (Figure 1A); however only
the increase in Fyn appears significant (Additional file 2:
Figure S2A). PAG-suppression also resulted in a dramatic
increase in basal tyrosine phosphorylation, which was
further enhanced upon TCR cross-linking (Figure 1B).
The augmented basal tyrosine phosphorylation and en-
hanced Src kinase activity correlate well with previous re-
ports that PAG is a negative regulator of Src kinases
[4,5,10]. Further analysis using phospho-specific reagents
demonstrated that in the absence of PAG the phosphoryl-
ation of the activatory tyrosine residues of the Src kinases,
ZAP-70, and PLCγ1 were also enhanced (Figure 1B and
Additional file 2: Figure S2B). We previously showed that
PAG negatively regulates Ras by recruiting p120 RasGAP
into the lipid rafts and that upon PAG-suppression, Ras
activity increases 5-fold [15]. Notably, the expression of
Csk and RasGAP are unaffected by the loss of PAG, indi-
cating that although these negative regulators are present,
in the absence of PAG they are no longer functional. To
demonstrate that the effect we observe is due to the loss
of PAG, we re-expressed a resistant PAG molecule and
show that the phenotype can be reverted (Figure 1C).
PAG-suppression results in an enhanced basal tyrosine
phosphorylation as well as a basal activation of proximal
signaling molecules, such as pZAP70 and pPLCγ. This is
clearly reduced by the expression of the resistant PAG-
YFP protein (lane 3) as indicated by the filled arrows (also
Additional file 2: Figure S2C). The level of inducible phos-
phorylation (lane 4) is comparable to that seen in control
cells (lane 6). Since PAG over-expression is inhibitory to T
cells [4,10], it is not surprising that the induction of
pPLCγ upon CD3 stimulation is clearly reduced (lane 2
versus lane 6) as indicated by the open arrows (also
Additional file 2: Figure S2C). To investigate the mechan-
ism behind the enhanced Src kinase activity, we analyzed
the distribution of Csk using sucrose density gradients,
since PAG was initially proposed to function as a negative
regulator of Src kinases by recruiting Csk into the lipid
rafts [4] (Figure 1D). Indeed, reduced PAG expression re-
sults in a 50% decrease in Csk recruitment to the lipid
rafts, consistent with this regulatory mechanism. The re-
cruitment of LAT appears slightly increased (Additional
file 2: Figure S2D).
PAG suppression induces T-cell unresponsiveness
We next investigated freshly isolated human peripheral
blood T cells. Upon PAG suppression, we observed a simi-
lar trend showing enhanced proximal signaling (Figure 2A
and Additional file 3: Figure S3). We next looked to see
whether these enhanced proximal signals also translated
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Figure 1 PAG down-regulation enhances Src kinase activity and proximal signaling. (A) Jurkat T cells were transfected with either
non-targeting shRNA (ctrl) or PAGshRNA (PAGsh) and three days later lysed. The top panel shows the PAG downregulation. The Src family kinases
Fyn (middle) and Lck (bottom) were immunoprecipitated and in vitro kinase assay (IVK) performed. Phosphorylation was visualized by
autoradiography, the amount of precipitated kinase was determined by immunoblotting. Quantification of the kinase bands can be found in
Additional file 2: Figure S2. (B) The cells from (A) were stimulated with CD3 and CD28 antibodies as indicated and lysates immunoblotted with
specific antibodies. Actin staining is shown as a loading control. Quantification can be found in the supplemental figure. (C) Jurkat T cells were
transfected with either control or PAG shRNA and co-transfected with either PAG-YFP, which differs by two nucleotides within the targeting
region, or YFP alone. The YFP-tag was included to allow us to distinguish between the over-expressed protein and endogenous PAG. The figure
shows that PAG is suppressed, while the expression of PAG-YFP (the resistant molecule) is unaffected. Actin was included as a loading control.
The cells were then either left untreated or stimulated for 5 minutes with anti-CD3 (C305). Cell lysates were immunoblotted to analyze proximal
signaling as indicated. Actin staining was included as a loading control. Quantification can be found in the supplemental figure. (D) Jurkat T cells
were prepared as described in (A) and fractions 2–4 from sucrose density gradients pooled, separated by SDS-PAGE, blotted, and probed as
indicated. Each panel is representative of at least three independent experiments. The phosphotyrosine blot in (B) was originally published in
Blood: Smida, et al. 2007 [15]. Quantification can be found in the supplemental material (Additional file 2: Figure S2).
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Figure 2 Decreased proliferation in primary human T cells.
(A) Primary human T cells were transfected with siRNA
oligonucleotide targeted against Renilla (ctrl) or PAG (PAGsi). Three
days later, the cells were stimulated through CD3 plus CD28, lysed
and immunoblotted with the indicated antibodies. Actin staining is
shown as a loading control. The inset box shows the efficiency of
PAG downregulation. (B) Primary human T cells were transfected
with either Renilla siRNA (ctrl) or PAG siRNA (PAGsi) oligonucleotides
and left for three days to downregulate PAG. Then, the cells were
inoculated on a plastic plate coated with anti-CD3, anti-CD3+anti-
CD28, anti-CD3 plus addition of exogenous IL-2 or uncoated (w/o).
The incorporation of 3H-Thymidine was measured at 72 hours and is
shown as the mean value of triplicates (±SD). Data were analyzed by
the Student’s t-test (*, P<0.05; **, P<0.01; ***, P<0.001). (C) The cells
transfected as in (B) were stimulated on an anti-CD3+anti-CD28
coated plastic plate for three days and the cell survival was assessed
by annexin V-FITC and PI staining. Data are representative of three
independent experiments. The phosphotyrosine blot in (A) was
originally published in Blood: Smida, et al. 2007 [15]. Quantification
of the blots can be found in the supplemental material (Additional
file 3: Figure S3).
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transfected cells (Additional file 2: Figure 2B). This is in
contrast to Pag1-deficient murine T cells, which prolifer-
ated equally as well as wild type cells [20,21]. Previously,
we have shown that primary murine T cells receiving a
strong stimulus (such as TCR cross-linking with soluble
antibodies) undergo apoptosis [25]. Therefore we reck-
oned that the enhanced proximal signaling we observe
was actually being translated into a death-inducing
stimulus. However, further analysis showed no induc-
tion of apoptosis (Figure 2C) and no increase in caspase
3 activity or alteration in FasL expression (Additional
file 4: Figure S4A and S4B respectively). This led us to
conclude that the enhanced proximal signals were not
instructing these cells to die.
However, death is not the only response that a T cell
can give upon too strong stimulation. Further analysis of
PAG-suppression showed that these T cells clearly pos-
sess a defect in IL-2 production (Figure 3A) as well as
an inability to up regulate CD25/IL-2Rα expression
(Figure 3B). The inability of PAG-suppressed T cells to
upregulate the IL-2R may explain why the addition of
exogenous IL-2 did not rescue proliferation (Figure 2B).
Together, these data led us to conclude that instead of
directing T cells to die, the loss of PAG was actually
instructing them to become unresponsive.
T-cell unresponsiveness is not due to cell-cycle arrest or
protein degradation
A number of mechanisms are known that lead to T-cell
unresponsiveness. One such mechanism is the induc-
tion of cellular senescence via p53 activation, which in-
duces cell-cycle arrest and thereby prevents activated
oncogenes from inducing tumorigenesis [26]. We rea-
soned that since both Src kinases and Ras are known
oncogenes and we observe enhanced activity in these
enzymes, cell-cycle arrest might be induced. However,
we observed neither an increase in the level of active
p53, nor a decrease in pFOXO, which regulates cell
cycle progression via p27. Moreover, we found reduced
expression of the cell cycle inhibitors p21 and p53
in the nuclear extracts of PAG-suppressed cells
(Additional file 5: Figure S6A), leaving us to con-
clude that an induction of cell-cycle arrest was not
the mechanism responsible for unresponsiveness.
Alternatively, we hypothesized that the increased Src
kinase activity in PAG-knockdown cells might also lead to
the activation of other negative regulators that could sup-
press signaling. Indeed, when we extended our kinetic
analysis of ZAP-70 and PLCγ activation (Figure 3C), we
observed that control cells demonstrated a sustained acti-
vation, particularly of PLCγ (Additional file 6: Figure S5).
In contrast, PAG-suppressed cells initially showed an en-









































Figure 3 PAG down-regulation results in unresponsiveness. (A) Primary human T cells transfected either with Renilla (ctrl) or PAG (PAGsi)
siRNA were stimulated on an anti-CD3 coated plastic plate for 24 hours and the production of IL-2 was assessed by intracellular FACS staining.
(B) The cells treated as in (A) were used to determine the upregulation of surface CD25 expression by flow cytometry. In the histograms, white
bars represent ctrl, grey bars PAGsi. (*, P<0.05; **, P<0.01) (C) Primary human T cells transfected either with Renilla (ctrl) or PAG (PAGsi) siRNA
were stimulated with CD3+CD28 antibodies for the indicated time, lysed and subjected to Western blotting. The activation of ZAP70 and PLCγ
was determined by phospho-specific antibodies. Actin staining is shown for equal loading. Data are representative of three (A, B) or two
(C) independent experiments. Quantification is shown in the supplemental material (Additional file 6: Figure S5).
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regulatory pathway had indeed been activated.
As Fyn is thought to induce negative regulatory path-
ways in T cells [27], we investigated a known substrate of
Fyn, the E3 ubiquitin ligase Cbl. Within T cells, Cbl is
known to target several important signaling components
for degradation, which results in an abrogation of T-cell
signaling. Although we observed an increase in phospho-
Cbl upon PAG down-regulation, we saw no alteration in
the expression of Lck or ZAP-70, two well characterized
Cbl substrates [25,28] (Additional file 5: Figure S6B),
suggesting that this mechanism was also not enabled.
PAG suppression induces CTLA-4 hyper-phosphorylation
and Shp-1 recruitment
One of the best characterized negative regulators of T
cells is the co-stimulatory molecule CTLA-4 (cytotoxic
T lymphocyte antigen 4). The endocytic adaptor AP-1
sequesters CTLA-4 within the Golgi. However, upon T-
cell activation, tyrosine phosphorylation of CTLA-4 dis-
places AP-1, resulting in an increased surface expression
and the subsequent recruitment of inhibitory molecules,
such as the phosphatases Shp-2 and/or PP2A (reviewed
in [29-31]).
Our analysis of PAG-suppressed primary human T cells
showed no observable difference in either the level of sur-
face or total CTLA-4 expression (Figure 4A and 4B). How-
ever, when we isolated CTLA-4 by immunoprecipitation,
we found that PAG-suppression resulted in a dramaticenhancement in tyrosine phosphorylation compared to
control transfected cells, where CTLA-4 phosphorylation is
barely detectable (Figure 4B). This was not due to off-target
effects, as we observed exactly the same phenotype with
the multiplicity control; siRNA oligos targeting other
sequences within the PAG molecule (Figure 4C). Surpris-
ingly, the enhanced phosphorylation of CTLA-4 resulted
in a substantial recruitment of the phosphatase Shp-1
(Figure 4B, Figure 4C and Additional file 7: Figure S7),
whereas Shp-2 was undetectable. Like PAG, CTLA4 is also
reported to function from lipid rafts [32-34]; a membrane
compartment that is important for propagating TCR sig-
nals. Thus, although the suppression of PAG expression
resulted in enhanced proximal signaling, it fails to induce
functional T-cell responses possibly due to the induction
of an auxiliary negative feedback loop involving CTLA-4-
associated Shp-1. To test the validity of this mechanism, we
next looked to see whether Fyn, which shows increased ac-
tivity after PAG knockdown, was indeed responsible for
phosphorylating CTLA-4 in primary T cells. Previous re-
ports have demonstrated by co-expression that a number
of Src kinases (such as Fyn, Lyn, or Lck) are able to phos-
phorylate CTLA-4 [35-37]. In support of this mechanism,
we also found that Fyn associated with CTLA-4 (Figure 4B)
in primary T cells, as had previously only been shown by
co-expression [35,36]. When we immunoprecipitated
CTLA-4 from activated murine T cells (Figure 4D), we
found that CTLA-4 phosphorylation was indeed dramatic-

















































Figure 4 Enhanced Src kinase activity results in phosphorylation of CTLA-4. (A) Primary human T cells transfected with Renilla (ctrl) or
PAG (PAGsi) siRNA were stimulated for 72 hours on an anti-CD3+anti-CD28 coated plastic plate. The surface expression of CTLA-4 was
measured by extracellular FACS staining. (B) T cells transfected as in (A) were stimulated overnight on anti-CD3+anti-CD28 coated plastic
plate, lysed and CTLA-4 was immunoprecipitated. Samples were immunoblotted for phospho-tyrosine (4G10), Shp1, Shp2, Fyn, and CTLA-4.
Antibody control (Ab) was included in the IP’s. Panel left shows whole lysates. Data are representative of three independent experiments.
Quantification of the blots can be found in the supplemental material (Additional file 7: Figure S7). (C) To exclude an off-target effect of our
siRNA, a pool of three siRNAs (all differ from our sequence) was used for the same experiment as in (B). (D) Murine T cells from wildtype and
Fyn knockout mice were cultured for three days on anti-CD3+anti-CD28 coated plastic plate, lysed and CTLA-4 was immunoprecipitated.
Western blot of a phospho-tyrosine (4G10) and total CTLA-4 staining is shown. Panel left shows whole lysates. Data are representative of
two independent experiments. (E). The CTLA-4 mediated reduction of IFNγ production is abbrogated in Fyn−/− mice. Naïve (CD62Lhigh)
CD8+ T cells from WT or Fyn−/− mice were stimulated with anti-CD3/CD28/CTLA-4 or anti-CD3/CD28/Isotype-coupled microspheres. Surface
expression of the activation markers CD25 and CD44, as well as intracellular IFNγ expression were detected by flow cytometry after 2
days of activation.
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tested whether CTLA4 is functional in Fyn-deficient mice.
Naive CD8+ T cells were activated with immobilized anti-
bodies to CD3 and CD28 in the presence or absence of
CTLA-4 cross-linking. Based upon the upregulation of
CD25 and CD44, all cells appear to have been activated(Figure 4E left panel). As expected, cross-linking of CTLA-
4 inhibits the ability of WT cells to produce IFNγ [38],
whereas this inhibitory function is lost in the absence of
Fyn (Figure 4E right panel). These results support our
model that the enhanced Fyn activity observed upon PAG
suppression can activate alternative feedback mechanisms
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as a negative regulatory kinase in T-cell signaling [27].
Co-suppression of CTLA-4 restores proliferation in
PAG-suppressed cells
The final question was whether removing CTLA-4 is suffi-
cient to negate the effect of PAG suppression and restore
proliferation. Therefore, we compared the proliferative
capacity of control and PAG-suppressed T cells, both with
and without additional CTLA-4 suppression. Figure 5A
shows that the siRNA was effective at suppressing protein
expression for both PAG and CTLA-4. Figure 5B shows
that in the absence of PAG, T cells became unresponsive
(as shown in Figure 2B), while in the absence of CTLA-4,
T cells became hyper-proliferative. Interestingly, for T cells
in which both PAG and CTLA-4 were co-suppressed, the
proliferative capacity was equal to or better than that ob-
served for the control transfected cells, indicating that the
suppressive mechanism induced by PAG-suppression is
negated by removing CTLA-4. A similar trend was also
seen when we analyzed the proximal signaling in these
cells. Most strikingly, the suppression of CTLA-4 alone
resulted in an enhanced activation of PLCγ, which appears
to be reverted upon the removal of PAG (Figure 5C and
Additional file 8: Figure S8). The removal of PAG and
CTLA-4 counteract one another both functionally and
biochemically suggesting that both molecules regulate the
same pathway.
Discussion
Here, we verify the role of PAG as a negative regulator of
Src kinases. Additionally, in the absence of PAG, we identify
a fail-safe mechanism that induces T-cell unresponsiveness
via a Fyn-dependent phosphorylation of CTLA-4 (Figure 6).
Consistent with the negative regulatory function of PAG,
we observe both enhanced Src kinase activity and increased
basal tyrosine phosphorylation upon PAG suppression; a
phenotype that could be reverted by re-expressing a resist-
ant PAG molecule (Figure 1C). Interestingly, the
phosphotyrosine profiles (Figures 1B and 2A) show that the
transmembrane adaptor LAT (pp36/38) was also constitu-
tively phosphorylated in resting PAG-suppressed T cells,
indicating that the enhanced phosphorylation was not
restricted to direct substrates of the Src family kinases.
A similar phenotype of enhanced Src kinase activity was
observed upon Csk suppression [39]. However, the secre-
tion of IL-2 was enhanced in primary human T cells rather
than inhibited, as reported here. The differences observed
between PAG and Csk downregulation may be due to
Csk-independent functions of PAG for Src kinase regula-
tion. For Src, an SH2-domain-dependent interaction with
PAG was shown, which resulted in the sequestration of
Src into lipid rafts away from non-raft Src substrates, in-
hibition of downstream activation of MEK, ERK and Aktand suppression of Src-mediated oncogenic transform-
ation in the absence of Csk. Similarly, in these Csk−/−
cells a palmitoylation mutant of Fyn showed redistribution
away from lipid rafts and enhanced kinase activity, dem-
onstrating that lipid raft localisation inhibits Fyn activity
in the absence of Csk and independent of the presence of
the negative-regulatory tyrosine Y529 [13]. Our results
here show that downregulation of PAG releases this inhib-
ition. Despite unchanged raft-association of Fyn its activity
is now increased. Notably, despite the enhancement of
proximal TCR signaling, PAG suppression had no effect
upon ERK activation or calcium-flux (Additional file 9:
Figure S9). This may be due to the fact that activation of
these molecules is already maximal and therefore cannot
be further enhanced or that there is a spatial segregation
of activators and effectors. However, despite our inability
to influence these molecules, PAG-suppressed T cells still
became unresponsive due to a hyper-phosphorylation of
CTLA-4. Here, we show for the first time that Fyn is
largely responsible for CTLA-4 phosphorylation and func-
tion in primary T cells. These observations are supported
by previous studies using co-expression to show that Fyn
phosphorylates CTLA-4 [35-37] and also support the idea
that Fyn primarily contributes to negative regulation in T
cells [27].
One function of CTLA-4 is to reverse the TCR-
induced stop signal [40]. In line with this activity, we
previously reported that PAG-suppression resulted in
both an enhanced spontaneous and specific migration of
T cells [24].
To our knowledge, this is the first report demonstrat-
ing Shp-1 recruitment to CTLA-4. This fits with previ-
ous observations that CTLA-4 functions from the lipid
rafts [32-34] and targeting Shp-1 to the rafts blocks T-
cell activation [41]. In this context, Shp-1 could induce
unresponsiveness by inactivating key signaling molecules
such as Lck, ZAP-70, and PLCγ. Indeed, CTLA-4 has
previously been shown to inhibit phosphorylation of
ZAP-70 at Y319 [42] and in the absence of CTLA-4 we
observe enhanced phosphorylation of both ZAP70 and
PLCγ (Figure 5C and Additional file 8: Figure S8). Similarly,
the phosphorylation of ZAP-70 and PLCγ was abruptly
truncated following activation of PAG-suppressed cells
(Figure 3C). Previously, Shp-1 was shown to bind to phos-
phorylated peptides corresponding to the cytoplasmic tail
of CTLA-4 [42,43], however an involvement of Shp-1 was
ruled out, as CTLA-4 was shown to be inhibitory in moth-
eaten mice [44,45]. Given that CTLA-4 binds Shp-2 in
mice [46], one could attribute this differential recruitment
to either redundancy or species-specific differences, as
shown for LAIR-1 (leukocyte-associated Ig-like receptor-1)
[47,48].
Despite the hyper-phosphorylation of CTLA-4, we ob-
served no detectable increase in the levels of surface
Figure 6 Model of CTLA-4 induced T-cell unresponsiveness. 1. In resting T cells (left panel) PAG restricts mobility of the lipid rafts and recruits
Csk to the membrane, where it blocks activation of the Src family kinases. 2. In the absence of PAG (right panel) Fyn activity is increased, resulting
in enhanced proximal signaling events. 3. However, at a later time point enhanced Fyn activity also leads to hyper-phosphorylation of CTLA-4.
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Figure 5 CTLA-4 suppression restores the defect in proliferation caused by PAG suppression. Primary human T cells were transfected with
siRNAs targeting Renilla (ctrl), PAG (PAGsi), CTLA-4 (CTLA4si) or PAG + CTLA-4 (PAGsi+CTLA4si). Cells were then stimulated with indicated stimuli
for three days on a plastic plate. (A) To demonstrate the downregulation of protein expression by siRNAs, total cell lysate staining for PAG and
CTLA-4 is shown. (B) The proliferation was measured by 3H-Thymidin incorporation at 72 hours. Mean value of triplicates (±SD) is depicted. Data
were analyzed by the Student’s t-test (*, P<0.05; **, P<0.01). Data are representative of three independent experiments. (C) Primary human T cells
transfected with the siRNAs indicated were stimulated with CD3 antibodies for the indicated time, lysed and subjected to Western blotting. The
activation of ZAP70 and PLCg was determined by phospho-specific antibodies. Actin is shown for equal loading. Quantification of the blots can
be found in the supplemental material (Additional file 8: Figure S8).
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surprising, as CTLA-4 expression should be regulated
by phosphorylation of the YVKM motif within the cyto-
plasmic tail, which prevents binding of AP-2 and thereby
blocks endocytosis of the receptor [reviewed in 29-31].
However, Hu et al. (2001) have previously shown that
constitutively active Lck, or Fyn, phosphorylate CTLA-4
within the Golgi [37]. This supports our hypothesis that
pCTLA-4 may not need to be at the surface to function
and suggests that additional mechanisms besides phosphor-
ylation may regulate surface expression. An alternative in-
terpretation may be that the enhanced phosphorylation of
CTLA4 we observe also increases the rate of internaliza-
tion, such that there is no observable change in surface
expression.
While co-stimulation of CTLA-4 is known to inhibit
T-cell activation, it is interesting to consider that the in-
hibitory effect of CTLA-4 observed here is independent
of ligand, as the cells were stimulated with plate-bound
antibody and not antigen presenting cells. This is in
agreement with previous reports demonstrating ligand-
independent inhibitory functions for CTLA-4. First,
mice express a ligand-independent isoform of CTLA-4
that generates inhibitory signals [49,50]. Additionally,
the expression of a ligand-nonbinding CTLA-4 was suf-
ficient to inhibit T-cell proliferation and block cytokine
production on an otherwise CTLA-4-deficient back-
ground [51]. Also, recent reports have shown that the
cytoplasmic domain of CTLA-4 (ctCTLA-4) alone is
sufficient to inhibit T-cell activation and prevent auto-
immunity [52-54]. Taken together, these studies suggest
that competing with CD28 for ligand is only one of sev-
eral inhibitory mechanisms utilized by CTLA-4 and sup-
port the hypothesis that there is an intrinsic inhibitory
nature to CTLA-4. Since the majority of CTLA-4 is
intracellular, with only a minor fraction of molecules
(~10%) appearing on the cell surface [55], we consider it
likely that these molecules also have a function. The in-
hibitory nature of CTLA-4 is further supported by the
hyper-proliferative capacity of CTLA-4-suppressed T
cells to plate-bound antibody (Figure 5), which agrees
with previous reports showing that blocking CTLA-4
enhances proliferation [56,57]. This mechanism is sup-
ported by studies demonstrating the presence of intra-
cellular CTLA-4 in resting primary human T cells
[41,58]. Taken together, the data suggest that the mere
presence of CTLA-4 is inhibitory to T cells, as was re-
cently shown for PD-1 [59]. A similar inhibitory role has
been proposed for Shp-1 [44,60], and a possible contribu-
tion of CTLA-4 to setting the activation threshold within
T cells has been suggested for primed TCR-transgenic
cells [61]. This intrinsic inhibitory mechanism may also
contribute to the unresponsive nature of regulatory T
cells, which constitutively express CTLA-4 [60,62].Conclusion
We demonstrate that PAG is indeed a negative regulator in
T cells and show that the loss of PAG alone is not sufficient
to induce lymphocyte transformation. Instead, the en-
hanced Src kinase activity induced by the loss of PAG trig-
gers an auxiliary negative feedback loop involving CTLA-4.
Thus, it appears that multiple mechanisms have evolved to
ensure a tight regulation of T-cells. Indeed, the mechanism
identified here may explain T-cell unresponsiveness in older
mice, which show decreased PAG expression, enhanced
proximal signaling, and defective proliferation [63]. Further
analysis has also shown that aged mice upregulate the ex-
pression of inhibitory co-stimulatory molecules, such as
CTLA-4 and PD-1 [64]. The importance of this mechanism
for inducing T-cell unresponsiveness may now take on a
broader context, as PAG expression has been shown to be
suppressed by epigenetic histone modification [65]. Indeed,
data generated by the Immunological Genome project
[www.immgen.org] suggest that within the population of
αβ T cells, Pag1 expression is lowest in tumor-infiltrating
CD8+ and splenic CD4+CD25+Foxp3+ regulatory T cells,
both of which are CTLA-4+.
The loss of PAG has also revealed a novel contribution
of CTLA-4 to setting the activation threshold within T
cells. This suggests that in addition to lacking functional
regulatory T cells, the CTLA-4 knockout mice also pos-
sess a lower threshold for activation, which may contrib-
ute to the hyper-proliferative syndrome that leads to
autoimmunity in these mice [29,30,46]. Indeed in vitro
stimulation of T cells from Ctla4-deficient mice showed
an enhanced expression of CD69 per cell [66] indicative
of stronger TCR signaling.
Methods
Antibodies and reagents
The following hybridoma supernatants were produced
within our Institute: mouse anti-phosphotyrosine (clone
4G10), mouse anti-CD3ε (clones OKT-3 (IgG) and
MEM-92 (IgM)), mouse anti-TCRβ (clone C305, IgM),
mouse anti-CD28 (clone 248.23.2, IgM), and mouse
anti-PAG (clone MEM-255). Mouse anti-Fyn-02 was
kindly provided by Dr. Vaclav Horejsi. Rabbit anti-
phospho-Src (pY418), mouse anti-Lck (3A5), rabbit anti-
Lck and rabbit anti-Fyn were purchased from BioSource,
mouse anti-Pan-Ras (Ab-4) from Oncogene, mouse anti-
RasGAP (B4F8), mouse anti-human CTLA-4 (BNI3),
hamster anti-mouse CTLA-4 (UC10-4 F10-11), anti-
mouse CD8 (196), anti-mouse CD25 (7D4), anti-mouse
CD44 (IM7), anti-mouse CD62L (MEL14), anti-mouse
IFNγ (AN18.17.24) were from BD Biosciences, goat anti-
CTLA-4 (C-19), rabbit anti-Shp1 (C19), mouse anti-
Shp2 (B1), rabbit anti-GFP/YFP (FL), and rabbit anti-
Csk (C20) from Santa Cruz. Phospho-specific antibodies
against p-ZAP70 (pY319) and p-PLCγ1 (pY783) were
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antibodies goat-anti-mouse-HRP and goat-anti-rabbit-
HRP were obtained from Dianova, donkey-anti-goat-
HRP from Santa Cruz. Phorbol myristate acetate (PMA)
and N-dodecyl β-D-maltoside (lauryl maltoside (LM))
were purchased from Calbiochem. Igepal (Nonidet P-40
(NP-40)), ionomycin, glutathione-sepharose, GDP and
mouse anti-β-actin (AC-15) were from Sigma. Human
recombinant interleukin 2 (IL-2) was purchased from
Tebu-bio. The PAG-YFP vector was kindly provided by
Dr. Shigeyuki Nada.
Cell cultures
Approval for these studies was obtained from the Ethics
Committee of the Medical Faculty at the Otto-von-
Guericke University, Magdeburg, Germany. Informed
written consent was obtained in accordance with the
Declaration of Helsinki. Human T cells were prepared as
previously described [15]. The Jurkat E6.1 T cell line was
cultured as described [24].
Mouse experiments
Fyn knockout mice were kindly provided by Dr. Rose
Zamoyska and maintained under pathogen-free condi-
tions. Experiments were performed according to the
guidelines of the state of Sachsen-Anhalt. Splenic T cells
were purified by non-T cell depletion using a Pan T cell
isolation Kit [Miltenyi Biotec]. Purified T cells were cul-
tured for three days on 24-well-plates coated with anti-
CD3 (2C11; 10 μg/ml) plus anti-CD28 (1 μg/ml) [both
BD]. 20x106 mouse T cells were used for immunoprecip-
itation with hamster anti-mouse CTLA-4 as described
for human T cells below.
Alternatively, crosslinking of CTLA-4 (CD152) on CD8
cells was performed using latex microspheres coated with
antibodies. In brief, 107 microspheres/ml were suspended
in PBS with CD3 (0.75 μg/ml), CD28 (2.5 μg/ml), CTLA-4
or a hamster control antibody (A19-3, 8 μg/ml) and incu-
bated for 1 h at 37°C, followed by washing in PBS and
blocking with complete media. CD8 T cells (1.5x106/ml)
were stimulated at a ratio of 1:1 with antibody-coupled mi-
crospheres. Specificity of crosslinking of CD152 with
antibody-coupled microspheres was controlled by stimulat-
ing naive CD8 T cells (CD8+ CD62Lhigh) of C57BL/6 OT-1
CTLA4−/− mice with CD3, CD28, and CTLA-4 or CD3,
CD28, and isotype-coupled microspheres for 2d followed
by analyzing expression of IFNγ as described below.
RNA inhibition
For PAG siRNA, the human sequence 50 GCGAUAC
AGACUCUCAACATT 30 corresponding to Shima et al.
[23] was either used as RNA oligos [Invitrogen] in pri-
mary human T cells or cloned as shRNA into the vector
pCMS3-EGFP for Jurkat T cells. All constructs weresequenced to ensure integrity. To rule out off-target ef-
fects of our PAG siRNA oligonucleotide, some experi-
ments were repeated with an siGENOME SMARTpool
of 4 siRNAs purchased from Thermo Scientific. For
CTLA-4 downregulation, a STEALTH pool of three
siRNAs [Invitrogen] was used.
For transfection, primary human T-cells (8x106) were
washed with PBS, resuspended in 200 μl Optimem
[Invitrogen] and transfected with siRNA in a 4 mm cuvette
[BioRad] with a square-wave pulse using a Genepulser X-
cell [BioRad] at 1000 V, 0.5 ms, 2 pulses, gap between
pulses 5 s. Jurkat T cells were electroporated with 30 μg
DNA in a 4 mm cuvette [BioRad] using Gene Pulser II
[BioRad] at 210 V, 950 μF. Protein expression was moni-
tored by Western blotting to determine the time required
for optimal suppression.
Cell stimulation
Primary human T cells were washed once with RPMI
medium without FBS and stimulated with CD3 (MEM-
92) plus CD28 antibody supernatants for indicated times
at 37°C (100 μl per 5x106 cells). Stimulation was stopped
with 1 ml ice-cold TBS and the cells lysed immediately.
Jurkat T cells were stimulated in the same way with anti-
TCR (C305) plus anti-CD28 supernatants.
Immunoprecipitation and western blotting
Cell lysates were prepared as previously described [15]. For
CTLA-4 immunoprecipitation, 10x106 activated T cells
were lysed in 250 μl lysis buffer and immunoprecipitated
with 1 mg/ml BSA, CTLA-4 antibody, and protein A seph-
arose for 2–18 h with rotation at 4°C as described [15].
In vitro kinase assay
Cells (10x106/sample) were lysed and immunoprecipitated
with either Fyn-02 or rabbit anti-Lck and Protein A-
Sepharose. In vitro kinase assays were performed as previ-
ously described [4].
Proliferation assays
The incorporation of [3H]-thymidine (0.3 μCi/well, spe-
cific activity 50 Ci/mmol) [PerkinElmer] at the end of
the three day stimulation was measured by liquid scintil-
lation as previously described [15].
Flow cytometry
Transfected primary human T cells were stimulated on a
24-well-plate coated with anti-CD3 or anti-CD3 plus
anti-CD28 for indicated time, washed once with PBS
and stained with CD25-FITC, FasL-PE or CTLA-4-PE
[all BD] for 20 min on ice. After one wash with cold
PBS, samples were analyzed on a FACS Calibur using
the Cell Quest Pro software [BD].
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was added at 1 μg/ml for the last 6 hours of culture and
the cells were stained with IL-2-PE [Miltenyi Biotec] using
the Inside Stain Kit [Miltenyi Biotec] according to the
manufacturer’s instructions.
The activated caspase 3 within the stimulated cells was
detected with the Caspase-3 Detection Kit [Calbiochem]
according to the manufacturer’s instructions.
Intracellular staining of murine T cells for IFNγ
production was performed using fixed cells. Fixation
was performed by incubation of cells in 2% Formal-
dehyde (Merck) diluted in PBS for 20 min on ice.
Permeabilization was achieved using 0.5% Saponin
(Sigma) diluted in PBS/BSA.
Apoptosis assay
Cell apoptosis was determined using the Annexin V-
FITC Apoptosis Detection Kit [Bender MedSystems]
according to the manufacturer’s instructions.
Sucrose gradient centrifugation
Lipid raft fractionation was performed as previously de-
scribed [4].
Quantification
Films were scanned with an Epson Perfection 4990
Photo scanner and the optical density determined using
Kodak 1D 3.6 software. The density of the band of inter-
est was normalized using the loading control to the
value in the control cells.
Statistical analysis
All statistical analyses were performed using GraphPad
Prism software. Comparison of two samples was performed
using two-tailed Student’s t-test. One sample t-tests were
used where indicated. Multiple samples were compared by
a one-way ANOVA combined with a Tukey’s Multiple
Comparison Post Test.
Additional files
Additional file 1: Figure S1. Kinetics of PAG suppression. Jurkat T cells
were transfected with plasmids encoding PAG shRNA and the change in
PAG expression monitored by Western blotting using the MEM-255
antibody. Actin staining is shown as a loading control. All samples were
run on a single gel and blotted. The added line indicates where
irrelevant samples were removed. Quantification of the data is provided
in the histogram. Data were analyzed by the Student’s t-test (*, P<0.05;
***, P<0.001). (TIFF 5024 kb)
Additional file 2: Figure S2. Quantification of Figure 1. (A) The
autophosphorylation of Fyn and Lck in the kinase assays (IVK) (Figure 1A)
were normalized with respect to the loading controls. The values for PAG
siRNA was set to 1.0 and a One-Sample t test analysis was performed
(shown is the mean ± SEM; *, P<0.05, n = 3). (B) The relative signal
intensities of p-Src (pY416), p-ZAP-70, and p-PLCγ in Figure 1B were
normalized with respect to the loading controls and the peak value setto 1.0 (the mean ± SEM is shown). Data are representative of p-ZAP-70
and p-PLCγ, n = 5, and pY416, n = 3 independent experiments. (C) The
relative signal intensities of p-ZAP-70 and p-PLCγ in Figure 1C were
normalized to the loading control. The peak value of the YFP-transfected
control was set to 1.0 and the mean ± SEM is shown (*, P<0.05, n = 3).
(D) The relative signal intensities of the blots for Csk and LAT in
Figure 1D are shown. The data is normalized to the ctrl siRNA and the
mean ± SEM is shown (n = 3). Grey bars (ctrl), black bars (PAGsi). The
data have not been corrected for multiple testing. (TIFF 14756 kb)
Additional file 3: Figure S3. Quantification of Figure 2. The relative
signal intensities of p-Src (pY416), p-ZAP-70, and p-PLCγ in Figure 2A
were normalized with respect to the loading controls and the peak value
set to 1.0 (the mean ± SEM is shown). Data are representative of p-ZAP
-70 and p-PLCγ, n = 3, and pY416, n = 2 independent experiments. (TIFF
11468 kb)
Additional file 4: Figure S4. Strong signaling does not induce
apoptosis. Primary human T cells transfected either with Renilla (ctrl) or
PAG (PAGsi) siRNA were stimulated on an anti-CD3+anti-CD28 coated
plastic plate for three days. (A) The activation of caspase 3 was
determined using FITC-conjugated DEVD-FMK. Profiles of unstimulated
(grey line) versus stimulated (black line) cells are shown. White bars (ctrl),
grey bars (PAGsi). (B) The upregulation of FasL was analyzed by flow
cytometry. Profiles of unstimulated (grey line) versus stimulated (black
line) cells are shown. Data are representative of three independent
experiments.
Additional file 5: Figure S6. T-cell unresponsiveness is not due to
oncogene-induced senescence or enhanced Cbl activity. (A) Enhanced
SFK activity does not result in oncogene-induced senescence. Primary
human T cells transfected with Renilla (ctrl) or PAG (PAGsi) siRNAs were
stimulated for 72 hours on an anti-CD3+anti-CD28 coated plastic plate.
Isolation of cytoplasmic and nuclear fractions was performed as
previously described (10). Briefly, cells were resuspended in an hypotonic
buffer and incubated with 10% NP-40. After centrifugation at 2000 rpm,
5 min, 4oC, the cytoplasmic fraction was obtained. Pellets were washed
and lysed in a stringent lysis buffer for 1 hour at 4oC with agitation.
Samples were then centrifuged at 13000 rpm, 10 min, 4oC and the
supernatant was taken as the nuclear fraction. Both fractions were loaded
on a 12% acrylamide gel and immunoblotted with phospho-p53, total
p53, total p21 [all from Exbio] and pFOXO1 antibodies [Cell Signaling].
Lamin A [BioLegend] and GAPDH [Abcam] antibodies were used as
markers to detect nuclear and cytoplasmic fraction respectively. Data are
representative of three independent experiments. (B) PAG suppression
enhances phospho-Cbl, but does not affect Lck or ZAP-70 expression.
Primary human T cells transfected with Renilla (ctrl) or PAG (PAGsi)
siRNAs were stimulated with anti-CD3+anti-CD28 for up to 24 hours,
lysed and immunoblotted for phosphorylation of Cbl (pY731) [Cell
Signaling] and total expression of ZAP-70 [BD] and Lck [Biosource]. Actin
staining is shown as a loading control. Data are representative of two
independent experiments.
Additional file 6: Figure S5. Quantification of Figure 3. The relative
signal intensities of p-ZAP-70 and p-PLCγ in Figure 3C were normalized
to the loading control. The peak value of the control sample was set to
1.0. Data from two independent experiments are shown, in both cases
the control samples show a sustained kinetic, whereas the signal in the
PAG siRNA samples peaks earlier and terminates. (TIFF 14933 kb)
Additional file 7: Figure S7. Quantification of Figure 4. The blots from
the CTLA-4 immunoprecipitates were analyzed. The control values set to
1.0 and a One-Sample t test analysis was performed (shown is the
mean ± SEM; *, P<0.05, n = 4). As shown in Figure 4, a significant
increase in the phosphorylation of CTLA-4 and recruitment of Shp1 is
observed, while the amount of Fyn and CTLA-4 remain unchanged.
Additional file 8: Figure S8. Quantification of Figure 5. The relative
signal intensities of p-ZAP-70 and p-PLCγ in Figure 5C were normalized
with respect to the loading controls and the peak value set to 1.0 (the
mean ± SEM is shown). Data are representative of at least three
independent experiments.
Additional file 9: Figure S9. PAG suppression does not affect
TCR-induced ERK activation or calcium flux. (A) Jurkat T cells transfected
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with anti-CD3+anti-CD28 for the indicated time, lysed and
immunoblotted for pERK [Cell Signaling]. Actin staining is shown for
equal loading. Data are representative of three independent experiments.
(B) Intracellular calcium flux was measured in primary human T cells
transfected either with Renilla (ctrl; grey dashed line) or PAG siRNA
(PAGsi, black solid line). Transfected T cells were washed with RPMI 1640
without phenol red and loaded with 5 μg/ml Indo-1 [Invitrogen] for
45 min at 37oC. The cells were washed briefly and incubated for an
additional 30 min before measuring the FL4 (510/20 nm) versus FL5
(400/40 nm) ratio on an LSR1 flow cytometer [BD]. The cells were
stimulated first with 50 μg CD3 (MEM-92) antibody supernatant and then
with ionomycin (1 μg/ml). The addition of CD3 antibody and ionomycin
is indicated by the filled and empty triangle, respectively. One
representative experiment of three is shown.
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